S
CORT icon

SignatureFD’s Corcept Therapeutics CORT Stock Holding History

SignatureFD’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.6K Buy
1,053
+542
+106% +$32.7K ﹤0.01% 1499
2026
Q1 		$20.6K Buy
511
+30
+6% +$1.12K ﹤0.01% 2191
2025
Q4 		$16.7K Sell
481
-18
-4% -$1.41K ﹤0.01% 2199
2025
Q3 		$41.5K Buy
499
+25
+5% +$1.81K ﹤0.01% 1736
2025
Q2 		$34.8K Sell
474
-8
-2% -$580 ﹤0.01% 1785
2025
Q1 		$55.1K Buy
482
+23
+5% +$1.4K ﹤0.01% 1511
2024
Q4 		$23.1K Buy
459
+10
+2% +$524 ﹤0.01% 1996
2024
Q3 		$20.8K Hold
449
– – ﹤0.01% 2023
2024
Q2 		$14.6K Hold
449
– – ﹤0.01% 2110
2024
Q1 		$11.3K Sell
449
-50
-10% -$1.18K ﹤0.01% 2256
2023
Q4 		$16.2K Sell
499
-53
-10% -$1.46K ﹤0.01% 2028
2023
Q3 		$15K Buy
552
+53
+11% +$1.53K ﹤0.01% 2003
2023
Q2 		$11.1K Buy
499
+28
+6% +$644 ﹤0.01% 2184
2023
Q1 		$10.2K Buy
471
+27
+6% +$592 ﹤0.01% 2200
2022
Q4 		$9.02K Hold
444
– – ﹤0.01% 2200
2022
Q3 		$11K Hold
444
– – ﹤0.01% 2024
2022
Q2 		$11K Sell
444
-44
-9% -$959 ﹤0.01% 2062
2022
Q1 		$11K Buy
488
+267
+121% +$5.68K ﹤0.01% 2107
2021
Q4 		$4K Buy
221
+44
+25% +$893 ﹤0.01% 2470
2021
Q3 		$3K Sell
177
-13
-7% -$272 ﹤0.01% 2506
2021
Q2 		$4K Sell
190
-164
-46% -$3.65K ﹤0.01% 2338
2021
Q1 		$8K Buy
354
+237
+203% +$6.33K ﹤0.01% 1935
2020
Q4 		$3K Buy
117
+40
+52% +$843 ﹤0.01% 2109
2020
Q3 		$1K Buy
+77
New +$1.23K ﹤0.01% 2387

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SignatureFD's CORT Position: Q2 2026 in Review

SignatureFD increased its Corcept Therapeutics (CORT) stake by 106% in Q2 2026, buying an estimated $32.7K and bringing the position to 1,053 shares worth $91.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1499.

SignatureFD first reported a position in CORT in Q3 2020 and has held it in 24 quarters since. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • SignatureFD held 1,053 shares of Corcept Therapeutics worth $91.6K as of Q2 2026.
  • SignatureFD bought 542 Corcept Therapeutics shares in Q2 2026, an estimated $32.7K.
  • Corcept Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1499 holding.
  • SignatureFD first reported a position in Corcept Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.